Development Level

Tbio 2 | 10,625
Tchem 1 | 1,890

Disease

ovarian cancer 3 | 8,484
psoriasis 3 | 6,685
Cancer 2 | 2,346
Hypersensitivity reaction type II disease 2 | 235
Stomach Neoplasms 2 | 282
acute quadriplegic myopathy 2 | 1,157
adrenocortical carcinoma 2 | 1,427
atypical teratoid / rhabdoid tumor 2 | 4,369
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
cystic fibrosis 2 | 1,665
ductal carcinoma in situ 2 | 1,745
ependymoma 2 | 2,514
glioblastoma 2 | 5,572
interstitial cystitis 2 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
malignant mesothelioma 2 | 3,162
nephrosclerosis 2 | 329
non-small cell lung cancer 2 | 2,798
pediatric high grade glioma 2 | 2,712
ulcerative colitis 2 | 2,087
Acute Promyelocytic Leukemia 1 | 31
Acute kidney injury 1 | 65
Adenoma 1 | 165
Amyotrophic lateral sclerosis type 8 1 | 8
Arsenic Poisoning 1 | 59
Arthritis 1 | 248
Becker muscular dystrophy 1 | 187
COPD 1 | 113
Carcinoma 1 | 2,147
Contact Dermatitis 1 | 80
Dermatologic disorders 1 | 65
Disease Progression 1 | 125
Down syndrome 1 | 548
Duchenne muscular dystrophy 1 | 602
Endometritis 1 | 21
Gastrointestinal system disease 1 | 50
Human immunodeficiency virus infectious disease 1 | 92
IGA Glomerulonephritis 1 | 454
Inflammatory bowel disease 1 | 142
Kidney disease 1 | 396
Leukemia, Myelocytic, Acute 1 | 113
Lymphopenia 1 | 35
Macroglobulinemia 1 | 17
Mammary Neoplasms, Experimental 1 | 150
Neoplasm Metastasis 1 | 138
Nerve Degeneration 1 | 73
Pancreatic Neoplasm 1 | 79
Peripheral Neuropathy 1 | 303
Rheumatoid Arthritis 1 | 1,160
Separation anxiety disorder 1 | 6
Severe Combined Immunodeficiency 1 | 46
Social phobia 1 | 10
Ureterocele 1 | 10
Vascular disease 1 | 281
Vitiligo 1 | 71
Waldenstrons macroglobulinemia 1 | 765
active Crohn's disease 1 | 918
astrocytic glioma 1 | 2,241
astrocytoma 1 | 1,493
breast carcinoma 1 | 1,614
colon cancer 1 | 1,475
cutaneous lupus erythematosus 1 | 1,056
dermatomyositis 1 | 933
diabetes mellitus 1 | 1,663
fascioscapulohumeral muscular dystrophy 1 | 100
fibroadenoma 1 | 557
gastric carcinoma 1 | 832
group 4 medulloblastoma 1 | 1,875
inflammatory breast cancer 1 | 404
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
juvenile dermatomyositis 1 | 1,189
limb girdle muscular dystrophy 2I 1 | 56
lung carcinoma 1 | 2,844
medulloblastoma, large-cell 1 | 6,234
non diabetic and post-ischemic heart failure 1 | 200
non primary Sjogren syndrome sicca 1 | 840
oligodendroglioma 1 | 2,849
osteosarcoma 1 | 7,933
pancreatic cancer 1 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
pilocytic astrocytoma 1 | 3,086
pituitary cancer 1 | 1,972
primary pancreatic ductal adenocarcinoma 1 | 1,271
primitive neuroectodermal tumor 1 | 3,031
sonic hedgehog group medulloblastoma 1 | 1,482
spina bifida 1 | 1,064
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis 1 | 1,557
uncontrolled asthma 1 | 67

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 2 | 11,971
Enzyme 1 | 4,146

Grant Application

5R01NS028182-17 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Receptor-type tyrosine-protein phosphatase F PTPRF Tchem Enzyme -2.06547 112.4 157
Syndecan-1 SDC1 Tbio Non-IDG -3.20112 1682.0 803
CD44 antigen CD44 Tbio Non-IDG -3.80016 6460.0 2499